Korea S.E.
23:00:00 16/05/2024 BST
5-day change
1st Jan Change
13,830
KRW
-1.21%
-1.21%
-13.24%
HLscience Co., Ltd. authorizes a Buyback Plan.
The Board of Directors of HLscience Co., Ltd. has authorized a buyback plan on September 30, 2022.
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
25/05/23
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
25/05/23
CI
HLscience Co., Ltd.'s Equity Buyback announced on September 30, 2022, has expired with 153,589 shares, representing 2.94% for KRW 2,999.38 million.
24/05/23
CI
HLscience Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
20/03/23
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022.
04/01/23
CI
HLscience Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
30/09/22
CI
HLscience Co., Ltd. authorizes a Buyback Plan.
29/09/22
CI
HLscience Co., Ltd.(KOSDAQ:A239610) dropped from S&P Global BMI Index
20/09/21
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on March 24, 2020.
24/09/20
CI
HLscience Co., Ltd's Equity Buyback announced on March 24, 2020, has expired with 60,620 shares, representing 1.2% for KRW 2,988.45 million.
23/09/20
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on March 24, 2020.
24/06/20
CI
HLscience Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
24/03/20
CI
HLscience Co., Ltd. authorizes a Buyback Plan.
23/03/20
CI
HLscience Co., Ltd.(KOSDAQ:A239610) added to S&P Global BMI Index
23/09/19
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on May 17, 2017.
17/11/17
CI
HLscience Co., Ltd.'s Equity Buyback announced on May 17, 2017, has expired with 82,172 shares, representing 1.6% for KRW 1,993.68 million.
16/11/17
CI
Tranche Update on HLscience Co., Ltd.'s Equity Buyback Plan announced on May 17, 2017.
18/08/17
CI
HLscience Co., Ltd. announces an Equity Buyback.
17/05/17
CI
HLscience Co., Ltd. authorizes a Buyback Plan.
16/05/17
CI
HLscience Co., Ltd. has completed an IPO in the amount of KRW 40.80 billion.
27/10/16
CI
Health-Love Co., Ltd. has filed an IPO.
17/06/16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-13.24% 52.93M +16.86% 8.48B +5.05% 7.6B +4.89% 6.39B -5.23% 3.75B -6.58% 3.71B -3.55% 1.36B -28.64% 1.11B +18.12% 1.02B -8.60% 924M
Special Foods & Wellbeing Products
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
HLSCIENCE CO., LTD. 
